Evidence from randomised trials on the long-term effects of hormone replacement therapy
Top Cited Papers
- 1 September 2002
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 360 (9337) , 942-944
- https://doi.org/10.1016/s0140-6736(02)11032-4
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Menopausal Hormone Replacement Therapy and Risk of Ovarian CancerJAMA, 2002
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Cardiovascular Disease Outcomes During 6.8 Years of Hormone TherapyJAMA, 2002
- Quality-of-Life and Depressive Symptoms in Postmenopausal Women After Receiving Hormone TherapyJAMA, 2002
- A Clinical Trial of Estrogen-Replacement Therapy after Ischemic StrokeNew England Journal of Medicine, 2001
- Postmenopausal Hormone Therapy and Risk of StrokeCirculation, 2001
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Design of the Women’s Health Initiative Clinical Trial and Observational StudyControlled Clinical Trials, 1998
- Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancerThe Lancet, 1997
- Decreased Risk of Fractures of the Hip and Lower Forearm with Postmenopausal Use of EstrogenNew England Journal of Medicine, 1980